LEXICON PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $113.6M | $64.1M |
| FY2022 | $48.6M | $117.1M | $46.3M |
| FY2023 | $99.5M | $93.1M | $22.5M |
| FY2024 | $100.3M | $146.0M | $66.7M |
| FY2025 | $49.4M | $107.5M | $34.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $113.6M | $64.1M |
| FY2022 | $48.6M | $117.1M | $46.3M |
| FY2023 | $99.5M | $93.1M | $22.5M |
| FY2024 | $100.3M | $146.0M | $66.7M |
| FY2025 | $49.4M | $107.5M | $34.3M |